The reality is simpler than the hype: BPC-157 and TB-500 are not FDA-approved drugs Clinics generally cannot lawfully prescribe or administer them for routine patient care Research use only is not a loophole Research distribution is currently the only compliant framework Understanding this protects researchers, providers, and consumers and keeps legitimate science separate from risky shortcuts.
Heliyon 2025:1 remi N, remi MM (2025) Oxidative/nitrosative stress, apoptosis, and redox signaling: key players in neurodegenerative diseases
Tendon and ligament injuries that were nagging at week 4 may show meaningful improvement
Glazier A, Tutschka PJ, Farmer ER, & Santos GW (1983) Graft-versus-host disease in cyclosporine A-treated rats after syngeneic and autologous bone marrow reconstitution
The injections provide visible and lasting results on both cosmetic and health aspects
Rangaswami J, Bhalla V, de Boer IH, et al